109 related articles for article (PubMed ID: 8906288)
21. [Migraine and serotonin: mechanisms and treatments].
Jacquy J
J Pharm Belg; 1996; 51(1):43-6. PubMed ID: 8882447
[No Abstract] [Full Text] [Related]
22. [A lesson on the purity of pharmaceutical products derived from biotechnology: eosinophilia-myalgia syndrome].
Boll Chim Farm; 1995; 134(7):394-5. PubMed ID: 7546544
[No Abstract] [Full Text] [Related]
23. Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
Margolin L
J Rheumatol; 2003 Mar; 30(3):628-9. PubMed ID: 12610828
[No Abstract] [Full Text] [Related]
24. The eosinophilia-myalgia syndrome and tryptophan.
Belongia EA; Mayeno AN; Osterholm MT
Annu Rev Nutr; 1992; 12():235-56. PubMed ID: 1503805
[No Abstract] [Full Text] [Related]
25. Eosinophilia-myalgia syndrome: the aftermath.
Sack KE; Criswell LA
South Med J; 1992 Sep; 85(9):878-82. PubMed ID: 1523446
[TBL] [Abstract][Full Text] [Related]
26. [Eosinophilia-myalgia syndrome].
Heuschling C
Bull Soc Sci Med Grand Duche Luxemb; 1992; 129(2):17-23. PubMed ID: 1340406
[No Abstract] [Full Text] [Related]
27. Genetic and biochemical changes of the serotonergic system in migraine pathobiology.
Gasparini CF; Smith RA; Griffiths LR
J Headache Pain; 2017 Dec; 18(1):20. PubMed ID: 28194570
[TBL] [Abstract][Full Text] [Related]
28. [The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
Szeimies RM; Meurer M
Dtsch Med Wochenschr; 1993 Feb; 118(7):213-20. PubMed ID: 8440161
[TBL] [Abstract][Full Text] [Related]
29. Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
Esper JJ; Nigro MA; Wishnow R; Barnett T; Perrotta AL; Richardson W
J Am Osteopath Assoc; 1992 Aug; 92(8):1056-8. PubMed ID: 1429067
[TBL] [Abstract][Full Text] [Related]
30. 5-Hydroxytryptamine and pain modulation in man: a clinical pharmacological approach with tryptophan and parachlorophenylalanine.
Sicuteri F; Anselmi B; Del Bene E; Galli P
Acta Vitaminol Enzymol; 1975; 29(1-6):66-8. PubMed ID: 146417
[TBL] [Abstract][Full Text] [Related]
31. Role of serotonin in therapy of depression and related disorders.
Fuller RW
J Clin Psychiatry; 1991 May; 52 Suppl():52-7. PubMed ID: 1674251
[TBL] [Abstract][Full Text] [Related]
32. Presence of peak X and related compounds: the reported contaminant in case related 5-hydroxy-L-tryptophan associated with eosinophilia-myalgia syndrome.
Johnson KL; Klarskov K; Benson LM; Williamson BL; Gleich GJ; Naylor S
J Rheumatol; 1999 Dec; 26(12):2714-7. PubMed ID: 10606395
[No Abstract] [Full Text] [Related]
33. [Scleroderma and environment. III. Eosinophilia-myalgia syndrome and L-tryptophan].
Bournerias I; Castot A
Ann Dermatol Venereol; 1991; 118(12):962-8. PubMed ID: 1799247
[No Abstract] [Full Text] [Related]
34. [Eosinophilia myalgia syndrome, toxic oil syndrome].
Niiyama T; Higuchi I
Ryoikibetsu Shokogun Shirizu; 2001; (35):358-60. PubMed ID: 11555954
[No Abstract] [Full Text] [Related]
35. [5-HT receptors. Significant target group in the treatment of migraine].
Dahlöf C; Edvinsson L
Lakartidningen; 1993 Feb; 90(7):569-74. PubMed ID: 8437466
[No Abstract] [Full Text] [Related]
36. The lessons of eosinophilia-myalgia syndrome.
Duffy J
Hosp Pract (Off Ed); 1992 Apr; 27(4A):65-9, 73-80, 83-90. PubMed ID: 1560091
[No Abstract] [Full Text] [Related]
37. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from L-tryptophan associated with eosinophilia-myalgia syndrome.
Williamson BL; Tomlinson AJ; Mishra PK; Gleich GJ; Naylor S
Chem Res Toxicol; 1998 Mar; 11(3):234-40. PubMed ID: 9544622
[TBL] [Abstract][Full Text] [Related]
38. 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.
Sicuteri F; Anselmi B; Del Bianco PL
Psychopharmacologia; 1973; 29(4):347-56. PubMed ID: 4267603
[No Abstract] [Full Text] [Related]
39. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin].
Schubert S; Trautmann F; Dreher R
Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039
[TBL] [Abstract][Full Text] [Related]
40. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer.
Slutsker L; Hoesly FC; Miller L; Williams LP; Watson JC; Fleming DW
JAMA; 1990 Jul; 264(2):213-7. PubMed ID: 2355442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
